TOWA Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥55,000 million, operating profit of ¥12,200 million and profit attributable to owners of parent of ¥8,500 million or ¥339.88 basic earnings per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,000 JPY | +0.55% | -2.48% | +54.28% |
Jun. 06 | Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch | MT |
May. 21 | Jefferies Adjusts TOWA’s Price Target to 16,000 Yen From 12,000 Yen, Keeps at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.28% | 1.7B | |
+49.68% | 201B | |
+80.79% | 43.42B | |
+52.78% | 38.14B | |
-12.31% | 28.19B | |
+27.93% | 23.14B | |
-9.83% | 12.02B | |
+168.07% | 11.21B | |
+83.03% | 7.34B | |
-17.70% | 5.22B |
- Stock Market
- Equities
- 6315 Stock
- News TOWA Corporation
- TOWA Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023